DEEPBLUE

COVID-19 (SARS-CoV-2) Antigen Test Kit

(Colloidal Gold)

ANTIGEN TEST KIT Anhui Deepblue COVID-19 (SARS-CoV-2) Antigen Test Kit

The self-test approved COVID-19 antigen rapid test is used for the qualitative detection of SARS-CoV-2 antigens and delivers results within 15 minutes.

The COVID-19 (SARS-CoV-2) Antigen Test Kit (Colloidal Gold) is used for in vitro qualitative detection of the antigen of SARS-CoV-2 in humans via anterior nasal, nasopharyngeal or oropharyngeal swab, applying the double antibody-sandwich method and colloidal gold immunochromatography.

The double antibody-sandwich method can ensure a low antibody cross-reaction, effectively improving the product's sensitivity and specificity and reducing false positives. It can be used for early screening of infection and is an effective supplement to nucleic acid (PCR) detection.

Product Information

Anhui Deepblue COVID-19 (SARS-CoV-2) Antigen Test Kit

Type
Antigen Rapid Test; self-test approved
Test Principle
Double Antibody-Sandwich; Colloidal Gold
Specimen Collection
Anterior Nasal, Nasopharyngeal or Oropharyngeal swab
Time to Result
15 - 20 min
Storage
4°C to 30°C
Period of Validity
24 months

Let's dive in. We are ready if you are.

Our team is looking forward to meet your challenges and assist you anytime.

Contact Sales
Contents
25
Sterilized Nasal Swabs
25
Test Cassettes
25
Antigen Extraction Tubes
25
Extraction Reagents
1
Tube Rack
1
Instruction Manual (English)
Clinical Results
Sensitivity
96,4%
Specificity
99,8%

Disclaimer

Negative results do not exclude infection with SARS COV-2, especially for people who have recently come into contact with the virus. Follow-up examinations with a recognized reference method (e.g., RT-PCR) should be considered in order to exclude infection with these persons. Positive results can be due to an earlier or present infection with non-SARS-CoV-2 coronavirus strains, such as e.g. Coronavirus HKU1, NL63, OC43 or 229e. Results of antibody tests should not be used as the sole basis for the diagnosis or exclusion of SARS COV-2 infection or information about the infection status. As with all PharmacT products, the results achieved are a supplement to other information available to medical personnel. The treatment of patients should be based on a combination of symptoms, clinical signs, anamnesis, other laboratory tests and therapeutic reactions.

Ready to get in touch? We'd love to dicuss your requirements.